E&Investment
VC Fund
Seoul, South Korea
E&Investment is a venture capital firm based in Seoul, South Korea.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 10%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries E&Investment invests in
Stages E&Investment invests in
Countries E&Investment invests in
Round sizes
Round size
- Series A
- $3.6M–$38M
- Series B
- $5M–$30M
- Series C
- $9.7M–$15M
Investment Focus
Industry
- Biotechnology 7 (23%)
- Medical 4 (13%)
- Biopharma 4 (13%)
- Health Care 4 (13%)
- Pharmaceutical 4 (13%)
Stage
- Series A 12 (39%)
- Series B 9 (29%)
- Series C 3 (10%)
- Venture - Series Unknown 3 (10%)
- Funding Round 2 (6%)
Country
- South Korea 22 (71%)
- United States 3 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Plastal is a mechanical and chemical engineering company that offers polymer, metal, and mold injection services. The company specializes in using its core technology required for bonding between metal and plastic resin, mold technology, injection conditions, and milling capabilities, enabling manufacturing companies to avail themselves of theproducts they desire. | $13.1M / Series B / Oct 16, 2025 | ||
| MBD is a biotechnology company that specializes in 3D cell culture platforms. | $11.9M / Series C / Aug 14, 2025 | ||
| IBEX Medical System designs and develops an automatic control and mirroring system that uses an LCD touch screen interface to provide quick and accurate operational service. The company offers a hyperbaric oxygen chamber that meets the design standards for hyperbaric pressure vessels and international certification standards. In addition tochecking chamber conditions and patient information on mobile devices, medical staff can also check it in real-time on their mobile devices. | $9.7M / Series C / Mar 14, 2025 | ||
| Sizzle is a company that provides an integrated process analysis solution based on accumulated experience. | $16.3M / Venture - Series Unknown / Jan 15, 2025 | ||
| Mepseng is the eveloper of micro-engineered physiological systems designed to create human model-centered drugs. The company's systems carry out fundamental biological research in an environment equipped with an organ-level function of connected human tissues instead of in a traditional in-vitro experimental model using 2D cell culture,enabling researchers to further verify in a physiologically relevant environment to validate the discovery of new biological mechanisms. | $14.9M / Series C / Nov 19, 2024 | ||
| Mardi Mercredi operates a clothing store offering easy-to-wear everyday clothes for women, men, and children. In addition to jackets, jeans, tops, shirts, and other accessories, the company offers French-inspired designer clothes as per customers' needs, including jackets, jeans, and tops. | $37.6M / Series A / Sep 19, 2023 | ||
| AIMMO is the developer of a data annotation platform with custom workflow designs, labeler analytics, and real-time communication functions. The company was founded in 2016 by SeungTaek Oh and is headquartered in Seongnam-si, Gyeonggi-do, Republic of Korea. | $11M / Sep 06, 2023 | ||
| Superblock vision removes centralized web servers and puts blockchain run by the people in the system's core. | $8M / Series A / Jul 21, 2023 | ||
| Smart Food Networks is a food commerce company that provides food commerce and logistics services. | $29.8M / Series B / May 16, 2023 | ||
| Crocus Energy is a software company that utilizes artificial intelligence to enhance transparency in electricity consumption within large, energy-intensive facilities. This approach offers valuable insights and clarity regarding the consequences of each decision made. Additionally, the company manages the fast charging system for electric vehiclesknown as 'Acello EV' and the power optimization control solution referred to as 'Acello GRID'. | $5M / Series B / Mar 23, 2023 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does E&Investment invest in?
E&Investment invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Series B stage. Most of the 31 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is E&Investment's check size?
E&Investment typically joins rounds of $3.6M–$38M at Series A, $5M–$30M at Series B and $9.7M–$15M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds E&Investment participates in.
When did E&Investment last invest?
The most recent investment recorded for E&Investment closed in Oct 2025. Shizune tracks 31 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
